11:06 AM EDT, 06/26/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were lower Friday morning, decreasing 0.4% to 1,883.22 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech companies Evaxion ( EVAX ) and Abivax ( ABVX ) , which gained 5.4% and 4.5% respectively. They were followed by healthcare firm Grifols ( GRFS ) and drink and brewing giant Anheuser-Busch Inbev ( BUD ) , which added 1.4% and 1.1%, respectively.

The decliners from continental Europe were led by Agomab Therapeutics ( AGMB ) and steel producer ArcelorMittal ( MT ) , which fell 3.9% and 3.5% respectively. They were followed by energy company Equinor ( EQNR ) , which was down 1.3%.

From the UK and Ireland, the gainers were led by pharmaceutical company Compass Pathways ( CMPS ) and Autolus Therapeutics ( AUTL ) , which rose 5.6% and 2.8% respectively.

The decliners from the UK and Ireland were led by semiconductor company Arm (ARM) and Barclays ( BCS ) , which shed 4% and 1.3% respectively.